Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review

Marit Ahrens, John Haanen, Laurence Albiges, Marine Gross Goupil, Ekaterini Boleti, Gwenaelle Gravis, Aude Fléchon, Marc Oliver Grimm, Jens Bedke, Philippe Barthélémy, Daniel Castellano, Begona Mellado, Philipp Ivanyi, Sylvie Rottey, Anne Flörcken, Cristina Suárez, Jose P. Maroto, Viktor Grünwald, Sjoukje Oosting, Jindrich Kopecky, Stefanie Zschäbitz, Martin Boegemann, Tomas Buchler, Guenter Niegisch, Peter J. Goebell, Tom Waddell, Florence Joly, Frank Priou, Margitta Retz, Stefan Siemer, Uwe Zimmermann, Dorothee Deckbar, Iris Burkholder, Arndt Hartmann, Lothar Bergmann

Open source

DOI
10.1016/j.ejca.2026.116816
Published
2026-07
Container
European Journal of Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.116816,
  title = {Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review},
  author = {Marit Ahrens and John Haanen and Laurence Albiges and Marine Gross Goupil and Ekaterini Boleti and Gwenaelle Gravis and Aude Fléchon and Marc Oliver Grimm and Jens Bedke and Philippe Barthélémy and Daniel Castellano and Begona Mellado and Philipp Ivanyi and Sylvie Rottey and Anne Flörcken and Cristina Suárez and Jose P. Maroto and Viktor Grünwald and Sjoukje Oosting and Jindrich Kopecky and Stefanie Zschäbitz and Martin Boegemann and Tomas Buchler and Guenter Niegisch and Peter J. Goebell and Tom Waddell and Florence Joly and Frank Priou and Margitta Retz and Stefan Siemer and Uwe Zimmermann and Dorothee Deckbar and Iris Burkholder and Arndt Hartmann and Lothar Bergmann},
  year = {2026},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2026.116816},
  url = {https://doi.org/10.1016/j.ejca.2026.116816}
}

RIS

TY  - JOUR
TI  - Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review
AU  - Marit Ahrens
AU  - John Haanen
AU  - Laurence Albiges
AU  - Marine Gross Goupil
AU  - Ekaterini Boleti
AU  - Gwenaelle Gravis
AU  - Aude Fléchon
AU  - Marc Oliver Grimm
AU  - Jens Bedke
AU  - Philippe Barthélémy
AU  - Daniel Castellano
AU  - Begona Mellado
AU  - Philipp Ivanyi
AU  - Sylvie Rottey
AU  - Anne Flörcken
AU  - Cristina Suárez
AU  - Jose P. Maroto
AU  - Viktor Grünwald
AU  - Sjoukje Oosting
AU  - Jindrich Kopecky
AU  - Stefanie Zschäbitz
AU  - Martin Boegemann
AU  - Tomas Buchler
AU  - Guenter Niegisch
AU  - Peter J. Goebell
AU  - Tom Waddell
AU  - Florence Joly
AU  - Frank Priou
AU  - Margitta Retz
AU  - Stefan Siemer
AU  - Uwe Zimmermann
AU  - Dorothee Deckbar
AU  - Iris Burkholder
AU  - Arndt Hartmann
AU  - Lothar Bergmann
PY  - 2026
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2026.116816
UR  - https://doi.org/10.1016/j.ejca.2026.116816
ER  -

APA

Ahrens, M., Haanen, J., Albiges, L., Goupil, M. G., Boleti, E., Gravis, G., Fléchon, A., Grimm, M. O., Bedke, J., Barthélémy, P., Castellano, D., Mellado, B., Ivanyi, P., Rottey, S., Flörcken, A., Suárez, C., Maroto, J. P., Grünwald, V., Oosting, S., Kopecky, J., Zschäbitz, S., Boegemann, M., Buchler, T., Niegisch, G., Goebell, P. J., Waddell, T., Joly, F., Priou, F., Retz, M., Siemer, S., Zimmermann, U., Deckbar, D., Burkholder, I., Hartmann, A., & Bergmann, L. (2026). Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116816

Source records